RTW Biotech Opportunities Ltd
RTWFF
$1.64
$0.2820.59%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 580.81% | 364.19% | 96.37% | 77.33% | 53.67% |
| Total Revenue | 580.81% | 364.19% | 96.37% | 77.33% | 53.67% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 580.81% | 364.19% | 96.37% | 77.33% | 53.67% |
| SG&A Expenses | 43.18% | 54.55% | 69.16% | 50.34% | 31.13% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 47.16% | 57.10% | 69.82% | 50.81% | 31.30% |
| Operating Income | 640.64% | 352.57% | -32.77% | -20.61% | -10.56% |
| Income Before Tax | -167.67% | -126.49% | -58.91% | -5.22% | 40.87% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -167.67% | -126.49% | -58.91% | -5.22% | 40.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -167.67% | -126.49% | -58.91% | -5.22% | 40.87% |
| EBIT | 640.64% | 352.57% | -32.77% | -20.61% | -10.56% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -155.84% | -119.70% | -74.15% | -29.64% | 8.76% |
| Normalized Basic EPS | -120.05% | 52.88% | 258.82% | 302.76% | 368.13% |
| EPS Diluted | -155.84% | -119.70% | -74.15% | -29.64% | 8.76% |
| Normalized Diluted EPS | -120.05% | 52.88% | 258.82% | 302.76% | 368.13% |
| Average Basic Shares Outstanding | 21.86% | 37.95% | 58.72% | 43.64% | 28.62% |
| Average Diluted Shares Outstanding | 21.86% | 37.95% | 58.72% | 43.64% | 28.62% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |